Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC)

被引：269

作者：

Camidge, D. Ross

Ou, Sai-Hong Ignatius

Shapiro, Geoffrey

Otterson, Gregory Alan

Villaruz, Liza Cosca

Villalona-Calero, Miguel Angel

Iafrate, A. John

Varella-Garcia, Marileila

Dacic, Sanja

Cardarella, Stephanie

Zhao, Weiqiang

Tye, Lesley

Stephenson, Patricia

Wilner, Keith D.

James, Leonard Philip

Socinski, Mark A.

机构：

[1] Univ Colorado, Ctr Canc, Aurora, CO USA

[2] Chao Family Comprehens Canc Ctr, Orange, CA USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Ohio State Univ, Dept Internal Med, Ctr Comprehens Canc, Columbus, OH 43210 USA

[5] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[6] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA

[7] Massachusetts Gen Hosp, Boston, MA 02114 USA

[8] Univ Colorado, Sch Med, Aurora, CO USA

[9] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA

[10] Pfizer Oncol, La Jolla, CA USA

[11] Rho Inc, Chapel Hill, NC USA

[12] Univ Pittsburgh, Pittsburgh, PA USA

来源：

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.8001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8001

引用

页数：1